NCT02447133View on ClinicalTrials.gov

TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Subjects Presenting With Normal Eyes
Interventions
DEVICE

3D OCT-1 Maestro

OCT Machine used for diagnostic purposes

Trial Locations (1)

07436

Topcon Medical Systems, Inc., Oakland

All Listed Sponsors
lead

Topcon Medical Systems, Inc.

INDUSTRY

NCT02447133 - TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro | Biotech Hunter | Biotech Hunter